So, what is this thing we call ‘empathetic technology’? While the two terms seem like antonyms, the intersection is proving to be a rich opportunity for innovation.
Artificial intelligence (AI) and machine learning (ML) are transforming the way cancers are detected and staged, offering new hope to the millions of people affected by the diseases every y
When European pharma company Norgine saw an unmet need in how patients were seeking information on one of its brands, they decided to implement a chatbot to help people find the answers they nee
With the 12th annual Rare Disease Day on the horizon, it’s a pertinent time to think about how one of the most exciting technological innovations of the last decade, artificial intelligence
A new study has found that blood thinning drugs improve outcomes for all heart failure patients, regardless of whether they already have atrial fibrillation (AF).
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.